Article
APAF1 Silencing Ameliorates Diabetic Retinopathy by Suppressing Inflammation, Oxidative…
Diabetes, Metabolic Syndrome and Obesity · 2024 · Ding Y, Chen L, Xu J, Feng Y, Liu Q
Key facts
| Title | APAF1 Silencing Ameliorates Diabetic Retinopathy by Suppressing Inflammation, Oxidative Stress, and Caspase-3/GSDME-Dependent Pyroptosis |
|---|---|
| First author | Ding Y, Chen L, Xu J, Feng Y, Liu Q |
| Journal | Diabetes, Metabolic Syndrome and Obesity |
| Published | Apr 10, 2024 |
| DOI | 10.2147/DMSO.S449049 |
| Devices mentioned | K021943, K040782, K043197, K053529, K061118, K071580, K072543, K073231, K081318, K082513, K120558, K132618 and 13 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIT, CIX, CJE, CKA, JAK and 5 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1